444
Views
3
CrossRef citations to date
0
Altmetric
Invited Reviews

Using a systematic approach to strategic innovation in laboratory medicine to bring about change

&
Pages 178-202 | Received 13 May 2021, Accepted 22 Oct 2021, Published online: 24 Jan 2022

References

  • Dixon-Woods M, Amalberti R, Goodman S, et al. Problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new. BMJ Qual Saf. 2011;20(Suppl 1):i47–i51.
  • Gorman D. On the barriers to significant innovation in and reform of healthcare. Intern Med J. 2015;45(6):597–599.
  • Grajewski B. 10 Barriers to healthcare innovation. The Guardian. 2015 Jan 23. p. 1–3. Available from: https://www.theguardian.com/healthcare-network/2015/jan/23/barriers-healthcare-innovation
  • Herzlinger RE. Why innovation in health care is so hard. Harv Bus Rev. 2006;84(5):58–66, 156.
  • Omachonu VK, Einspruch NG. Innovation in healthcare delivery systems: a conceptual framework. Innov J Public Sect Innov J. 2010;15(1):2.
  • Price CP, St John A. Innovation in healthcare. The challenge for laboratory medicine. Clin Chim Acta. 2014;427:71–78.
  • Arya SC, Hernandez JS, Dale JC, et al. Challenges and opportunities for medical directors in pathology and laboratory medicine: standardization, integration, and innovation. Am J Clin Pathol. 2010;133(5):819–820.
  • Bossuyt X, Verweire K, Blanckaert N. Laboratory medicine: challenges and opportunities. Clin Chem. 2007;53(10):1730–1733.
  • Bacher U, Shumilov E, Flach J, et al. Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use. Blood Cancer J. 2018;8(11):113.
  • Genzen JR, Burnham CD, Felder RA, et al. Challenges and opportunities in implementing total laboratory automation. Clin Chem. 2018;64(2):259–264.
  • Rifai N, Diamandis EP, Lo YM, et al. Advancing laboratory medicine through innovation: a tale of six inventors. Clin Chem. 2012;58(3):502–510.
  • Rifai N, Topol E, Chan E, et al. Disruptive innovation in laboratory medicine. Clin Chem. 2015;61(9):1129–1132.
  • Roohi A, Faust K, Djuric U, et al. Unsupervised machine learning in pathology: the next frontier. Surg Pathol Clin. 2020;13(2):349–358.
  • Naugler C, Church DL. Automation and artificial intelligence in the clinical laboratory. Crit Rev Clin Lab Sci. 2019;56(2):98–110.
  • Da Rin G, Zoppelletto M, Lippi G. Integration of diagnostic microbiology in a model of total laboratory automation. Lab Med. 2016;47(1):73–82.
  • Dolci A, Giavarina D, Pasqualetti S, et al. Total laboratory automation: do stat tests still matter? Clin Biochem. 2017;50(10–11):605–611.
  • Toouli G, Georgiou A, Westbrook J. Changes, disruption and innovation: an investigation of the introduction of new health information technology in a microbiology laboratory. J Pathol Inform. 2012;3:16.
  • Sharma A, Badea M, Tiwari S, et al. Wearable biosensors: an alternative and practical approach in healthcare and disease monitoring. Molecules. 2021;26(3):748.
  • Un KC, Wong CK, Lau YM, et al. Observational study on wearable biosensors and machine learning-based remote monitoring of COVID-19 patients. Sci Rep. 2021;11(1):4388.
  • Horgan D, Ciliberto G, Conte P, et al. Bringing onco-innovation to Europe’s healthcare systems: the potential of biomarker testing, real world evidence, tumour agnostic therapies to empower personalised medicine. Cancers (Basel). 2021;13(3):583.
  • Callahan D. Health care costs and medical technology. In: Crowley M, editor. Birth to death and bench to clinic: the Hastings Center bioethics briefing book for journalists, policymakers, and campaigns. Garrison (NY): The Hastings Center; 2008. p. 79–82.
  • Berner ES. Diagnostic error in medicine: implications for clinical laboratory scientists. Ann Clin Lab Sci. 2017;47(6):649–656.
  • Fernald D, Hamer M, James K, et al. Launching a laboratory testing process quality improvement toolkit: from the Shared Networks of Colorado Ambulatory Practices and Partners (SNOCAP). J Am Board Fam Med. 2015;28(5):576–583.
  • Herchline D, Rasooly IR, Bonafide C. Is that normal? A case of diagnostic error due to misinterpretation of laboratory findings. Hosp Pediatr. 2021;11:e78–e81.
  • Jafri L, Khan AH, Ghani F, et al. Error identification in a high-volume clinical chemistry laboratory: five-year experience. Scand J Clin Lab Invest. 2015;75(4):296–300.
  • Jakes A, McCue E, Cracknell A. Improving mid stream urine sampling: reducing labelling error and laboratory rejection. BMJ Qual Improv Rep. 2014;3(1):u204759.w2219.
  • Leen TK, Erdogmus D, Kazmierczak S. Statistical error detection for clinical laboratory tests. Annu Int Conf IEEE Eng Med Biol Soc. 2012;2012:2720–2723.
  • Nakhleh RE, Nose V, Colasacco C, et al. Interpretive diagnostic error reduction in surgical pathology and cytology: guideline from the College of American Pathologists Pathology and Laboratory Quality Center and the Association of Directors of Anatomic and Surgical Pathology. Arch Pathol Lab Med. 2016;140(1):29–40.
  • Naugler C, Ma I. More than half of abnormal results from laboratory tests ordered by family physicians could be false-positive. Can Fam Physician. 2018;64(3):202–203.
  • Noble MA, Restelli V, Taylor A, et al. Laboratory error reporting rates can change significantly with year-over-year examination. Diagnosis (Berl). 2018;5(1):15–19.
  • Oosterhuis WP, Bayat H, Armbruster D, et al. The use of error and uncertainty methods in the medical laboratory. Clin Chem Lab Med. 2018;56(2):209–219.
  • Restelli V, Taylor A, Cochrane D, et al. Medical laboratory associated errors: the 33-month experience of an on-line volunteer Canadian province wide error reporting system. Diagnosis (Berl). 2017;4(2):79–86.
  • Scobie A. Self-reported medical, medication and laboratory error in eight countries: risk factors for chronically ill adults. Int J Qual Health Care. 2011;23(2):182–186.
  • Amalberti R, Benhamou D, Auroy Y, et al. Adverse events in medicine: easy to count, complicated to understand, and complex to prevent. J Biomed Inform. 2011;44(3):390–394.
  • Kandalam V, Lau CK, Guo M, et al. Inappropriate repeat testing of complete blood count (CBC) and electrolyte panels in inpatients from Alberta, Canada. Clin Biochem. 2020;77:32–35.
  • Abimiku A, Timperi R, Blattner W. Laboratory innovation towards quality program sustainability. Curr HIV/AIDS Rep. 2016;13(4):202–208.
  • Beastall GH. Adding value to laboratory medicine: a professional responsibility. Clin Chem Lab Med. 2013;51(1):221–227.
  • Church DL, Naugler C. Essential role of laboratory physicians in transformation of laboratory practice and management to a value-based patient-centric model. Crit Rev Clin Lab Sci. 2020;57(5):323–344.
  • Crawford JM, Shotorbani K, Sharma G, et al. Improving American Healthcare through “clinical lab 2.0”: a project Santa Fe report. Acad Pathol. 2017;4:2374289517701067.
  • Ducatman BS, Ducatman AM, Crawford JM, et al. The value proposition for pathologists: a population health approach. Acad Pathol. 2020;7:2374289519898857.
  • Gill P, Guo M, Lau CK, et al. Implementation of an educational province-wide intervention to reduce redundant vitamin B12 testing: a cross-sectional study. Clin Biochem. 2020;76:1–4.
  • Cecchini ML. Antimicrobial resistance in G7 countries and beyond: economic issues, policies and options for action. Paris: Organisation for Economic Co-Operation and Devleopment (OECD). 2015; p. 1–75.
  • Collignon PJ, Conly JM, Andremont A, et al. World health organization ranking of antimicrobials according to their importance in human medicine: a critical step for developing risk management strategies to control antimicrobial resistance from food animal production. Clin Infect Dis. 2016;63(8):1087–1093.
  • Mendelson M, Matsoso MP. The World Health Organization global action plan for antimicrobial resistance. S Afr Med J. 2015;105(5):325.
  • Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS), United States, 2019. Table 044, 045. Hyattsville (MD): NCHS; [cited 2021 Apr 15]. Available from: https://www.cdc.gov/nchs/hus/contents2019.htm
  • Cha AE, Cohen RA. Problems paying medical bills, 2018. NCHS Data Brief, no 357. Hyattsville (MD): Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS); [cited 2021 Apr 15]. Available from: https://www.cdc.gov/nchs/products/index/htm.
  • Canadian Institute for Health Innovation (CIHI). National health expenditure trends 2020. Ottawa (Canada): CIHI; 2021.
  • Canadian Institute for Health Innovation (CIHI). Wait times for priority procedures in Canada - data table. Ottawa (Canada): CIHI; 2021.
  • Lelubre C, Anselin S, Zouaoui Boudjeltia K, et al. Interpretation of C-reactive protein concentrations in critically ill patients. Biomed Res Int. 2013;2013:124021.
  • Crowson CS, Rahman MU, Matteson EL. Which measure of inflammation to use? A comparison of erythrocyte sedimentation rate and C-reactive protein measurements from randomized clinical trials of golimumab in rheumatoid arthritis. J Rheumatol. 2009;36(8):1606–1610.
  • Yunus I, Fasih A, Wang Y. The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics. PLoS One. 2018;13(11):e0206527.
  • Church DL, Naugler C. Benefits and risks of standardization, harmonization and conformity to opinion in clinical laboratories. Crit Rev Clin Lab Sci. 2019;56(5):287–306.
  • Naugler C, Church DL. Clinical laboratory utilization management and improved healthcare performance. Crit Rev Clin Lab Sci. 2018;55(8):535–547.
  • Florkowski C, Don-Wauchope A, Gimenez N, et al. Point-of-care testing (POCT) and evidence-based laboratory medicine (EBLM) – does it leverage any advantage in clinical decision making? Crit Rev Clin Lab Sci. 2017;54(7–8):471–494.
  • Lippi G, Baird GS, Banfi G, et al. Improving quality in the preanalytical phase through innovation, on behalf of the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE). Clin Chem Lab Med. 2017;55(4):489–500.
  • Cariati F, D’Argenio V, Izquierdo R, et al. From laboratory bench to benchmark: technology transfer in laboratory medicine. Ann Transl Med. 2020;8(6):353.
  • Wieringa G. Teaching the pony new tricks: competences for specialists in laboratory medicine to meet the challenges of disruptive innovation. Clin Chem Lab Med. 2019;57(3):398–402.
  • Clearfield C, Tilcsik A. Meltdown: what plane crashes, oil spills, and dumb business decisions can teach us about how to succeed at work and home. New York (NY): Penguin Books; 2018.
  • MacNeil M, Koch M, Kuspinar A, et al. Enabling health technology innovation in Canada: Barriers and facilitators in policy and regulatory processes. Health Policy. 2019;123(2):203–214.
  • Sinek S. Start with why: how great leaders inspire everyone to take action. New York (NY): Penguin Group Inc.; 2009.
  • Keeley L, Pikkel R, Quinn B, et al. Ten types of innovation: the discipline of building breakthroughs. Hoboken (NJ): John Wiley & Sons; 2013.
  • Taylor JR, Thompson PJ, Genzen JR, et al. Opportunities to enhance laboratory professionals' role on the diagnostic team. Lab Med. 2017;48(1):97–103.
  • Ciarametaro M, Houghton K, Wamble D, et al. The dollar or disease burden: caps on healthcare spending may save money, but at what “cost” to patients? Value Health. 2021;24(3):388–396.
  • Hernandez JS, Dale JC, Bennet KE, et al. Challenges and opportunities for medical directors in pathology and laboratory medicine: standardization, integration, and innovation. Am J Clin Pathol. 2010;133(1):8–13.
  • Pennestri F, Banfi G. Value-based healthcare: the role of laboratory medicine. Clin Chem Lab Med. 2019;57(6):798–801.
  • Amann J, Zanini C, Rubinelli S. What online user innovation communities can teach us about capturing the experiences of patients living with chronic health conditions. A scoping review. PLoS One. 2016;11(6):e0156175.
  • Bird M, McGillion M, Chambers EM, et al. A generative co-design framework for healthcare innovation: development and application of an end-user engagement framework. Res Involv Engagem. 2021;7(1):12.
  • Rushforth A, Greenhalgh T. Personalized medicine, disruptive innovation, and “trailblazer” guidelines: case study and theorization of an unsuccessful change effort. Milbank Q. 2020;98(2):581–617.
  • Segarra-Oña M, Peiró-Signes Á, Verma R. Fostering innovation through stakeholders’ engagement at the healthcare industry: tapping the right key. Health Policy. 2020;124(8):895–901.
  • Sugarhood P, Wherton J, Procter R, et al. Technology as system innovation: a key informant interview study of the application of the diffusion of innovation model to telecare. Disabil Rehabil Assist Technol. 2014;9(1):79–87.
  • Odeebode AA, Okesina FA. Expectations of patients towards healthcare: a case study of Nigeria and Canada. Pak J Prof Psychol Res Pract. 2017;8(1):28–45.
  • Lateef F. Patient expectations and the paradigm shift of care in emergency medicine. J Emerg Trauma Shock. 2011;4(2):163–167.
  • Kash B, McKahan M. The evolution of measuring patient satisfaction. J Prim Health Care Gen Pract. 2017;1(1):4.
  • Calvert MJ, Marston E, Samuels M, et al. Advancing UK regulatory science and innovation in healthcare. J R Soc Med. 2021;114(1):5–11.
  • Cappellaro G, Ghislandi S, Anessi-Pessina E. Diffusion of medical technology: the role of financing. Health Policy. 2011;100(1):51–59.
  • Day-Duro E, Lubitsh G, Smith G. Understanding and investing in healthcare innovation and collaboration. J Health Organ Manag. 2020. DOI:https://doi.org/10.1108/JHOM-07-2019-0206
  • Silver B. mHealth: emerging trends in healthcare. PWC Global; 2021 [cited 2021 Apr 13]. Available from: https://www.pwc.com/gx/en/industries/healthcare/emerging-trends-pwc-healthcare/mhealth.html
  • Walters C. Changing demographics demand healthcare reforms: emerging trends in healthcare. PWC Global; 2021 [cited 2021 Apr 13]. Available from: https://www.pwc.com/gx/en/industries/healthcare/emerging-trends-pwc-healthcare/changing-demographics-healthcare-reform.html
  • Walters C. Depleting resources adding pressure to healthcare: emerging trends in healthcare. PWC Global; 2021 [cited 2021 Apr 13]. Available from: https://www.pwc.com/gx/en/industries/healthcare/emerging-trends-pwc-healthcare/depleting-resources.html
  • Walters C. The empowered customer: emerging trends in healthcare. PWC Global; 2021 [cited 2021 Apr 13]. Available from: https://www.pwc.com/gx/en/industries/healthcare/emerging-trends-pwc-healthcare/depleting-resources.html
  • Walters C. Chronic diseases and conditions are on the rise: emerging trends in healthcare. PWC Global; 2021 [cited 2021 Apr 13]. Available from: https://www.pwc.com/gx/en/industries/healthcare/emerging-trends-pwc-healthcare/chronic-diseases.html
  • Walters C. The distrusful customer: emerging trends in healthcare. PWC Global; 2021 [cited 2021 Apr 13]. Available from: https://www.pwc.com/gx/en/industries/healthcare/emerging-trends-pwc-healthcare/diy-non-traditional-healthcare.html
  • United Nations, Department of Economic and Social Affairs, Population Division. World population prospects 2019. New York (NY): United Nations; 2019.
  • World Health Organization (WHO), Department of Noncommunicable Diseases (NCDs) and Mental Health. Global action plan for the prevention and control of NCDs 2013–2020. 1st ed. Geneva (Switzerland): World Health Organization (WHO); 2013. p. 1–55.
  • Burwell SM, Townsend FF. (Chairs). Improving pandemic preparedness. Independent Task Force Report No. 78. New York (NY): Council on Foreign Relations, Inc.; 2020. p. 1–158.
  • Wang P, Kricka LJ. Current and emerging trends in point-of-Care technology and strategies for clinical validation and implementation. Clin Chem. 2018;64(10):1439–1452.
  • Christensen CM. The innovators dilemma: when new technologies cause great firms to fail. Boston (MA): Hravard Business Review Press; 2016.
  • Macfarlane F, Barton-Sweeney C, Woodard F, et al. Achieving and sustaining profound institutional change in healthcare: case study using neo-institutional theory. Soc Sci Med. 2013;80:10–18.
  • Occelli P, Quenon JL, Hubert B, et al. Development of a safety culture: initial measurements at six hospitals in France. J Healthc Risk Manag. 2011;30(4):42–47.
  • Taking the Pulse of Health Care and Politics: With more health-related topics becoming politicized, it may be hard to keep politics out of the exam room. ASH Clinical News. 2019 Sept 1. p. 1–10.
  • Bambra C, Fox D, Scott-Samuel A. Towards a politics of health. Health Promot Int. 2005;20(2):187–193.
  • Ireland S. Revealed: Countries With The Best Health Care Systems, 2021. CEOWORLD MAGAZINE; 2021 [cited 2021 Aug 1]. Available from: https://ceoworld.biz/2021/04/27/revealed-countries-with-the-best-health-care-systems-2021/
  • Canada Health Act Annual Report 2019–2020. Ottawa (Canada): Health Canada; 2021.
  • Pew Research Center (PRC). U.S. Politics & Policy. Public’s 2019 priorities: economy, health care, education and security all near top of list. PRC; 2019 [cited 2021 Apr 14]. Available from: https://www.people-press.org/2019/01/24/publics-2019-priorities-economy-health-care-education-and-security-allpnear-top-of-list/
  • Navarro V, Muntaner C, Borrell C, et al. Politics and health outcomes. Lancet. 2006;368(9540):1033–1037.
  • Rosenfarb N. The role of strategic planning in building business value: divestopedia; 2018. Available from: https://www.divestopedia.com/2/1112/pre-sale/preparation/the-role-of-strategic-planning-in-building-business-value
  • Navarro V, Shi L. The political context of social inequalities and health. Int J Health Serv. 2001;31(1):1–21.
  • Advanced Management Solutions (AMS). Data analytics – healthcare key performance indicators and metrics. London (Canada); 2021. Available from: https://www.amsol.ca/healthcare-key-performance-indicators-and.-metrics
  • Sibbald B. CMA okays private health care for waiting patients. CMAJ. 2005;173(6):585.
  • Bartsch SM, Ferguson MC, McKinnell JA, et al. The potential health care costs and resource use associated with COVID-19 in the United States. Health Aff (Millwood). 2020;39(6):927–935.
  • Trenti T. An evidence-based laboratory medicine approach to evaluate new laboratory tests. EJIFCC. 2018;29(4):259–263.
  • Guerrero-Fernandez de Alba I, Orlando V, Monetti VM, et al. Comorbidity in an older population with type-2 diabetes mellitus: identification of the characteristics and healthcare utilization of high-cost patients. Front Pharmacol. 2020;11:586187.
  • US Centers for Medicare and Medicaid Services (CMS). Clinical Laboratory Fee Schedule Files. CSM, editor. Baltimore (MA): CMS; 2021. Available from: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ClinicalLabFeeSched/Clinical-Laboratory-Fee-Schedule-Files
  • Esmail ED. Medical technology in Canada. Vancouver (Canada): Fraser Institute; 2008. p. 1–101.
  • Feulefack J, Sergi C. R&D implementation in a department of laboratory medicine and pathology: a systematic review based on pharmaceutical companies. Glob J Health Sci. 2015;7(4):70–82.
  • Lewis G. An objective approach to selecting a referral laboratory. MLO Med Lab Obs. 2010;42:32, 34–36.
  • Hendriksen JM, Geersing GJ, van Voorthuizen SC, et al. The cost-effectiveness of point-of-care D-dimer tests compared with a laboratory test to rule out deep venous thrombosis in primary care. Expert Rev Mol Diagn. 2015;15(1):125–136.
  • Hernandez JS. Cost-effectiveness of laboratory testing. Arch Pathol Lab Med. 2003;127(4):440–445.
  • Johnson K, Suriyaarachchi P, Kakkat M, et al. Yield and cost-effectiveness of laboratory testing to identify metabolic contributors to falls and fractures in older persons. Arch Osteoporos. 2015;10:226.
  • Kip MM, Schop A, Stouten K, et al. Assessing the cost-effectiveness of a routine versus an extensive laboratory work-up in the diagnosis of anaemia in Dutch general practice. Ann Clin Biochem. 2018;55(6):630–638.
  • Ouattara EN, Robine M, Eholie SP, et al. Laboratory monitoring of antiretroviral therapy for HIV infection: cost-effectiveness and budget impact of current and novel strategies. Clin Infect Dis. 2016;62(11):1454–1462.
  • Pandya A, Weinstein MC, Salomon JA, et al. Who needs laboratories and who needs statins?: comparative and cost-effectiveness analyses of non-laboratory-based, laboratory-based, and staged primary cardiovascular disease screening guidelines. Circ Cardiovasc Qual Outcomes. 2014;7(1):25–32.
  • Schechner V, Carmeli Y, Leshno M. A mathematical model of Clostridium difficile transmission in medical wards and a cost-effectiveness analysis comparing different strategies for laboratory diagnosis and patient isolation. PLoS One. 2017;12(2):e0171327.
  • Tan KE, Ellis BC, Lee R, et al. Prospective evaluation of a matrix-assisted laser desorption ionization-time of flight mass spectrometry system in a hospital clinical microbiology laboratory for identification of bacteria and yeasts: a bench-by-bench study for assessing the impact on time to identification and cost-effectiveness. J Clin Microbiol. 2012;50(10):3301–3308.
  • Aggarwal D, Kanitkar T, Narouz M, et al. Clinical utility and cost-effectiveness of bacterial 16S rRNA and targeted PCR based diagnostic testing in a UK microbiology laboratory network. Sci Rep. 2020;10(1):7965.
  • Asha SE, Chan AC, Walter E, et al. Impact from point-of-care devices on emergency department patient processing times compared with Central laboratory testing of blood samples: a randomised controlled trial and cost-effectiveness analysis. Emerg Med J. 2014;31(9):714–719.
  • May C. Agency and implementation: understanding the embedding of healthcare innovations in practice. Soc Sci Med. 2013;78:26–33.
  • Wright JR, Jr. When pathology and laboratory medicine becomes a commodity and health care becomes both its customer and owner. Acad Pathol. 2018;5:2374289518785373.
  • Owens PL. COVID-19-related hospitalizations in nine states, by race/ethnicity, 2020: statistical brief #272. Rockville (MD): Healthcare Cost and Utilization Project (HCUP) Statistical Briefs; 2006.
  • Galford RM, Frisch B, Greene C. Simple sabotage: a modern field manual for detecting & rooting out everyday behaviours that undermine your workplace. New York (NY): Harper Collins; 2015.
  • Morone JA. The health care bureaucracy: small changes, big consequences. J Health Polit Policy Law. 1993;18(3 Pt 2):723–739.
  • Rogers EM. Diffusion of innovations. 5th ed. New York (NY): Free Press; 2003.
  • Haden J. When Jeff Bezo’s 2-Pizza Teams Fell Short, He turnes to the Brilliant Model Amazon Uses Today. Inc. 2021. Available from: https://www.inc.com/jeff-haden/when-jeff-bezoss-two-pizza-teams-fell-short-he-turned-to-brilliant-model-amazon-uses-today.html.
  • Cannon J, Cannon J. Leadership lessons of the navy seals: battle-tested strategies for crating sucessful organizations and inspiring extraordinary results. New York (NY): McGraw-Hill; 2003.
  • Lublin JS. Smaller boards get bigger returns. The Wall Street Journal. 2014. Available from: https://www.wsj.com/articles/smaller-boards-get-bigger-returns-1409078629.
  • Wright JR, Jr. The American College of Surgeons, minimum standards for hospitals, and the provision of high-quality laboratory services. Arch Pathol Lab Med. 2017;141(5):704–717.
  • Palanica A, Fossat Y. COVID-19 has inspired global healthcare innovation. Can J Public Health. 2020;111(5):645–648.
  • Bayefsky M, Berkman BE. FDA’s proposed guidance for laboratory developed tests: how should regulators balance the risks and promise of innovation in clinical genetics? FDAs Food Drug Policy Forum. 2015;5(2):1–7.
  • Genzen JR, Mohlman JS, Lynch JL, et al. Laboratory-developed tests: a legislative and regulatory review. Clin Chem. 2017;63(10):1575–1584.
  • Desveaux L, Soobiah C, Bhatia RS, et al. Identifying and overcoming policy-level barriers to the implementation of digital health innovation: qualitative study. J Med Internet Res. 2019;21(12):e14994.
  • Ioannidis JP, Greenland S, Hlatky MA, et al. Increasing value and reducing waste in research design, conduct, and analysis. Lancet. 2014;383(9912):166–175.
  • Minogue V, Cooke M, Donskoy AL, et al. Patient and public involvement in reducing health and care research waste. Res Involv Engagem. 2018;4:5.
  • Bailie J, Laycock AF, Peiris D, et al. Using developmental evaluation to enhance continuous reflection, learning and adaptation of an innovation platform in Australian Indigenous primary healthcare. Health Res Policy Syst. 2020;18(1):45.
  • Greenhalgh T, Wherton J, Shaw S, et al. Infrastructure revisited: an ethnographic case study of how health information infrastructure shapes and constrains technological innovation. J Med Internet Res. 2019;21(12):e16093.
  • Mulberg AE, Bucci-Rechtweg C, Giuliano J, et al. Regulatory strategies for rare diseases under current global regulatory statutes: a discussion with stakeholders. Orphanet J Rare Dis. 2019;14(1):36.
  • Al-Shahi Salman R, Beller E, Kagan J, et al. Increasing value and reducing waste in biomedical research regulation and management. Lancet. 2014;383(9912):176–185.
  • Brown T. Change by design: how design thinking transforms organizations and inspires innovation. New York (NY): HarperCollins; 2009.
  • Mootee I. Design thinking for strategic innovation: what they can’t teach you at business or design school. Hobeken (NJ): Wiley; 2013.
  • US Federal Drug Administration (FDA). Laboratory flexible funding model cooperative agreement program. FDA; 2021. Available from: https://www.fda.gov/federal-state-local-tribal-and-territorial-officials/grants-and-cooperative-agreements/laboratory-flexible-funding-model-cooperative-agreement-program.
  • Lazzari MA. Developing a standard protocol for the introduction of new testing into a clinical laboratory. Lab Med. 2009;40(7):389–393.
  • Ma I, Lau CK, Ramdas Z, et al. Estimated costs of 51 commonly ordered laboratory tests in Canada. Clin Biochem. 2019;65:58–60.
  • Ma I, Guo M, Lau CK, et al. Test volume data for 51 most commonly ordered laboratory tests in Calgary, Alberta, Canada. Data Brief. 2019;23:103748.
  • Salinas M, Lopez-Garrigos M, Flores E, et al. Large-scale analysis evaluating regional variability in the request of laboratory tests in primary care and its potential economic impact. Lab Med. 2017;48(3):271–276.
  • Church DL, Hall P. Centralization of a regional clinical microbiology service: the Calgary experience. Can J Infect Dis. 1999;10(6):393–402.
  • Vandenberg O, Durand G, Hallin M, et al. Consolidation of clinical microbiology laboratories and introduction of transformative technologies. Clin Microbiol Rev. 2020;33(2):e00057-19.
  • Narula A, Yadav SK, Jahan A, et al. Pre-analytical error in a hematology laboratory: an avoidable cause of compromised quality in reporting. Clin Chem Lab Med. 2019;57(10):e262–e264.
  • Patel S, Nanda R, Sahoo S, et al. Congruity in quality indicators and laboratory performance. Indian J Clin Biochem. 2018;33(3):341–347.
  • Chandler WL, Brown AF, Chen D, et al. External quality assurance of platelet function assays: results of the College of American Pathologists Proficiency Testing Program. Arch Pathol Lab Med. 2019;143(4):472–482.
  • Crothers BA, Booth CN, Darragh TM, et al. False-positive Papanicolaou (PAP) test rates in the College of American Pathologists PAP education and PAP proficiency test programs: evaluation of false-positive responses of high-grade squamous intraepithelial lesion or cancer to a negative reference diagnosis. Arch Pathol Lab Med. 2014;138(5):613–619.
  • Karlon WJ, Naides SJ, Crosson JT, et al. Variability in testing for antineutrophil cytoplasmic antibodies: a survey of participants in the college of American Pathologists Proficiency Testing Program. Arch Pathol Lab Med. 2016;140(6):524–528.
  • Keeney M, Halley JG, Rhoads DD, et al. Marked variability in reported minimal residual disease lower level of detection of 4 hematolymphoid neoplasms: a survey of participants in the college of American pathologists flow cytometry proficiency testing program. Arch Pathol Lab Med. 2015;139(10):1276–1280.
  • Moncur JT, Bartley AN, Bridge JA, et al. Performance comparison of different analytic methods in proficiency testing for mutations in the BRAF, EGFR, and KRAS genes: a study of the college of American Pathologists Molecular Oncology Committee. Arch Pathol Lab Med. 2019;143(10):1203–1211.
  • Rhoads DD, Genzen JR, Bashleben CP, et al. Prevalence of traditional and reverse-algorithm syphilis screening in laboratory practice: a survey of participants in the college of American pathologists syphilis serology proficiency testing program. Arch Pathol Lab Med. 2017;141(1):93–97.
  • Zhao C, Crothers BA, Ghofrani M, et al. Misinterpretation rates of high-grade squamous intraepithelial lesion in the college of american pathologists gynecologic PAP education and PAP proficiency test program. Arch Pathol Lab Med. 2016;140(11):1221–1224.
  • Brack AP, Guo M, Ma I, et al. Use of the mean abnormal result rate (MARR) to gauge changes in family physicians’ selectivity of laboratory test ordering, 2010–2015. Am J Clin Pathol. 2017;148(5):436–440.
  • Buse JD, Donovan LE, Naugler CT, et al. Intervention to reduce unnecessary glucose tolerance testing in pregnant women. J Appl Lab Med. 2018;3(3):418–428.
  • Delvaux N, Piessens V, Burghgraeve T, et al. Clinical decision support improves the appropriateness of laboratory test ordering in primary care without increasing diagnostic error: the ELMO cluster randomized trial. Implement Sci. 2020;15(1):100.
  • Ma I, Guo M, Pillai DR, et al. Is the utilization of Helicobacter pylori stool antigen tests appropriate in an urban Canadian population? Am J Clin Pathol. 2020;153(5):686–694.
  • Jones GRD, Legg M. Report formatting in laboratory medicine - a call for harmony. Clin Chem Lab Med. 2018;57(1):61–65.
  • Palanivel H, Nair S, Subramaniyan A, et al. Dengue virus infection: need for appropriate laboratory tests for diagnosis and management of the condition in children during an outbreak. Indian J Pathol Microbiol. 2015;58(3):328–331.
  • Passiment E, Meisel JL, Fontanesi J, et al. Decoding laboratory test names: a major challenge to appropriate patient care. J Gen Intern Med. 2013;28(3):453–458.
  • Barrett BJ, Randell EW, Mariathas HH, et al. The effect of laboratory requisition modification, audit and feedback with academic detailing or both on utilization of blood urea testing in family practice in Newfoundland, Canada. Clin Biochem. 2020;83:21–27.
  • Rudolf JW, Baron JM, Dighe AS. Order indication solicitation to assess clinical laboratory test utilization: D-dimer order patterns as an illustrative case. J Pathol Inform. 2019;10:36.
  • Mohammed-Ali Z, Bhandarkar S, Tahir S, et al. Implementing effective test utilization via team-based evaluation and revision of a family medicine laboratory test requisition. BMJ Open Qual. 2021;10(1):e001219.
  • Arora A. Conceptualising artificial intelligence as a digital healthcare innovation: an introductory review. Med Devices (Auckl). 2020;13:223–230.
  • Pham Q, Shaw J, Morita PP, et al. The service of research analytics to optimize digital health evidence generation: multilevel case study. J Med Internet Res. 2019;21(11):e14849.
  • Gurevitch D. Robotics in the laboratory: where we have been and where we are going. MLO Med Lab Obs. 2007;39(11):34.
  • Wheeler MJ. Overview on robotics in the laboratory. Ann Clin Biochem. 2007;44(Pt 3):209–218.
  • Caputo A, D’Antonio A. Digital pathology: the future is now. Indian J Pathol Microbiol. 2021;64(1):6–7.
  • Humphries MP, Maxwell P, Salto-Tellez M. QuPath: the global impact of an open source digital pathology system. Comput Struct Biotechnol J. 2021;19:852–859.
  • Landaas EJ, Baird GS, Hansen RN, et al. Integrating formal technology assessment into an integrated healthcare delivery system: smart innovation. Int J Technol Assess Health Care. 2020;36(1):58–63.
  • Alekseyenko AV, Hamidi B, Faith TD, et al. Each patient is a research biorepository: informatics-enabled research on surplus clinical specimens via the living BioBank. J Am Med Inform Assoc. 2021;28(1):138–143.
  • Kumar A. Virtual global biorepository: access for all to speed-up result-oriented research. Cell Tissue Bank. 2020;21(3):361–365.
  • Nansumba H, Ssewanyana I, Tai M, et al. Role of a regulatory and governance framework in human biological materials and data sharing in National Biobanks: Case studies from Biobank Integrating Platform, Taiwan and the National Biorepository, Uganda. Wellcome Open Res. 2019;4:171.
  • Vasquez C, Kolinsky M, Djebah R, et al. Cohort profile: the Alberta Prostate Cancer Research Initiative (APCaRI) Registry and Biorepository facilitates technology translation to the clinic through the use of linked, longitudinal clinical and patient-reported data and biospecimens from men in Alberta, Canada. BMJ Open. 2020;10(10):e037222.
  • Bahcall S. Loonshots: how to nurture the crazy idease that win wars, cure diseases, and transform industries. New York (NY): St. Martens; 2019.
  • Barsh JC, Capozzi MM, Davidson J. Leadershsip and innovation. Seattle (WA): The McKinsey Quarterly; 2006.
  • Scotchmer S. Innovation and incentives. Boston (MA): The MIT Press; 2006.
  • Lou AH, Elnenaei MO, Sadek I, et al. Multiple pre- and post-analytical lean approaches to the improvement of the laboratory turnaround time in a large core laboratory. Clin Biochem. 2017;50(15):864–869.
  • Damato C, Rickard D. Using Lean-Six sigma to reduce hemolysis in the emergency care center in a collaborative quality improvement project with the hospital laboratory. Jt Comm J Qual Patient Saf. 2015;41(3):99–107.
  • Dundas NE, Ziadie MS, Revell PA, et al. A lean laboratory: operational simplicity and cost effectiveness of the Luminex xTAG™ respiratory viral panel. J Mol Diagn. 2011;13(2):175–179.
  • Gupta S, Kapil S, Sharma M. Improvement of laboratory turnaround time using lean methodology. Int J Health Care Qual Assur. 2018;31(4):295–308.
  • Inal TC, Goruroglu Ozturk O, Kibar F, et al. Lean six sigma methodologies improve clinical laboratory efficiency and reduce turnaround times. J Clin Lab Anal. 2018;32(1):e22180.
  • Letelier P, Guzman N, Medina G, et al. Workflow optimization in a clinical laboratory using lean management principles in the pre-analytical phase. J Med Biochemistry. 2021;40(1):26–32.
  • Morales-Contreras MF, Chana-Valero P, Suarez-Barraza MF, et al. Applying lean in process innovation in healthcare: the case of hip fracture. Int J Environ Res Public Health. 2020;17(15):5273.
  • Sugianto JZ, Stewart B, Ambruzs JM, et al. Applying the principles of lean production to gastrointestinal biopsy handling: from the factory floor to the anatomic pathology laboratory. Lab Med. 2015;46(3):259–264.
  • Thibert JB, Le Vacon F, Danic B. Lean management and medical laboratory: application in transfusionnal immuno-hematology. Ann Biol Clin (Paris). 2017;75(5):542–548.
  • White BA, Baron JM, Dighe AS, et al. Applying Lean methodologies reduces ED laboratory turnaround times. Am J Emerg Med. 2015;33(11):1572–1576.
  • Scott GD, Osborne TF, Gross SP, et al. Value-based intervention with hospital and pathology laboratory informatics: a case of analytics and outreach at the veterans affairs. J Pathol Inform. 2020;11:8.
  • Shirts BH, Jackson BR, Baird GS, et al. Clinical laboratory analytics: challenges and promise for an emerging discipline. J Pathol Inform. 2015;6:9.
  • Joseph T, Bickley T, Ziagura K. Using laboratory analytics to manage quality assurance and reduce errors in the laboratory. MLO Med Lab Obs. 2016 May;48(5):38.
  • Durant TJS, Peaper DR, Ferguson D, et al. Impact of COVID-19 pandemic on laboratory utilization. J Appl Lab Med. 2020;5(6):1194–1205.
  • Kruger EC, Banderker R, Erasmus RT, et al. The impact of COVID-19 on routine patient care from a laboratory perspective. S Afr Med J. 2020;110(12):1201–1205.
  • Virk RK, Wood T, Tiscornia-Wasserman PG. Impact of COVID-19 pandemic on functioning of cytopathology laboratory: experience and perspective from an academic Centre in New York. Cytopathology. 2021;32(3):304–311.
  • Agrawal R. COVID-19 and its impact on laboratory services. Indian J Pathol Microbiol. 2021;64(1):1–2.
  • Nikolayevskyy V, Holicka Y, van Soolingen D, et al. Impact of the COVID-19 pandemic on tuberculosis laboratory services in Europe. Eur Respir J. 2021;57(1):2003890.
  • Schlein L. WHO: equitable access to health care needed in Post-COVID world. Washington (DC): VOA News. 2021.
  • Shapiro DJ, Lindgren CE, Neuman MI, et al. Viral features and testing for streptococcal pharyngitis. Pediatrics. 2017;139(5):e20163403.
  • Lewnard JA, King LM, Fleming-Dutra KE, et al. Incidence of pharyngitis, sinusitis, acute otitis media, and outpatient antibiotic prescribing preventable by vaccination against group a Streptococcus in the United States. Clin Infect Dis. 2021;73:e47–e58.
  • Sayyahfar S, Fahimzad A, Naddaf A, et al. Antibiotic susceptibility evaluation of group a Streptococcus isolated from children with pharyngitis: a study from Iran. Infect Chemother. 2015;47(4):225–230.
  • Essack S, Bell J, Burgoyne D, et al. Point-of-care testing for pharyngitis in the pharmacy. Antibiotics (Basel). 2020;9(11):743.
  • Klepser DG, Klepser ME, Smith JK, et al. Utilization of influenza and streptococcal pharyngitis point-of-care testing in the community pharmacy practice setting. Res Social Adm Pharm. 2018;14(4):356–359.
  • Sciacovelli L, Lippi G, Sumarac Z, et al. Pre-analytical quality indicators in laboratory medicine: performance of laboratories participating in the IFCC working group “Laboratory Errors and Patient Safety”: project. Clin Chim Acta. 2019;497:35–40.
  • West DR, James KA, Fernald DH, et al. Laboratory medicine handoff gaps experienced by primary care practices: a report from the shared networks of collaborative ambulatory practices and partners (SNOCAP). J Am Board Fam Med. 2014;27(6):796–803.
  • Plebani M. Quality indicators to detect pre-analytical errors in laboratory testing. Clin Biochem Rev. 2012;33(3):85–88.
  • Doshi AM, Somberg M, Rosenkrantz AB. Factors influencing patients’ perspectives of radiology imaging centers: evaluation using an online social media ratings website. J Am Coll Radiol. 2016;13(2):210–216.
  • Bhatti Y, del Castillo J, Olson K, et al. Putting humans at the center of health care innovation. Harv Bus Rev. 2018;1–9.
  • Robinson S, Reed M, Quevillon T, et al. Patient perceptions and interactions with their web portal-based laboratory results. BMJ Health Care Inform. 2019;26(1):0.
  • Talboom-Kamp E, Tossaint-Schoenmakers R, Goedhart A, et al. Patients’ attitudes toward an online patient portal for communicating laboratory test results: real-world study using the eHealth impact questionnaire. JMIR Form Res. 2020;4(3):e17060.
  • Wakefield BJ, Turvey C, Hogan T, et al. Impact of patient portal use on duplicate laboratory tests in diabetes management. Telemed J E Health. 2020;26(10):1211–1220.
  • Song YE, Kang H, Park H. Algorithm to estimate the extended turnaround time including outpatient waiting time for blood specimen collection when a stand-alone queue ticket system not connectable to laboratory information system is used. Ann Clin Lab Sci. 2018;48(6):726–735.
  • Amukele TK, Sokoll LJ, Pepper D, et al. Can unmanned aerial systems (drones) be used for the routine transport of chemistry, hematology, and coagulation laboratory specimens? PLoS One. 2015;10(7):e0134020.
  • Andiric LR, Chavez LA, Johnson M, et al. Strengthening laboratory management toward accreditation, a model program for pathology laboratory improvement. Clin Lab Med. 2018;38(1):131–140.
  • Antonelli G, Sciacovelli L, Aita A, et al. Validation model of a laboratory-developed method for the ISO15189 accreditation: the example of salivary cortisol determination. Clin Chim Acta. 2018;485:224–228.
  • Okezue MA, Adeyeye MC, Byrn SJ, et al. Impact of ISO/IEC 17025 laboratory accreditation in Sub-Saharan Africa: a case study. BMC Health Serv Res. 2020;20(1):1065.
  • Rose GA, Johnson TV. Laboratory accreditation: why this quality matter matters. J Am Soc Echocardiogr. 2017;30(9):923–925.
  • Shpilsky D, Harinstein ME. Evaluation of the impact of laboratory accreditation on downstream outcomes. J Nucl Cardiol. 2020;28(6):2962–2964.
  • Christensen PA, Olsen RJ, Perez KK, et al. Real-time communication with health care providers through an online respiratory pathogen laboratory report. Open Forum Infect Dis. 2018;5(12):ofy322.
  • Clavijo A, Fallaw D, Coule P, et al. Communication of critical laboratory values: optimization of the process through secure messaging. Lab Med. 2020;51(1):e6–e11.
  • Datta SK, Pavani C. Active communication between laboratory physicians and clinicians: Need of the hour to improve patient outcomes. J Lab Physicians. 2019;11(2):174–175.
  • Bratan T, Stramer K, Greenhalgh T. ‘Never heard of it’- understanding the public’s lack of awareness of a new electronic patient record. Health Expect. 2010;13(4):379–391.
  • Hwang TJ, Lehmann LS, Kesselheim AS. Precision medicine and the FDA’s draft guidance on laboratory-developed tests. Nat Biotechnol. 2015;33(5):449–451.
  • Arney KR, Hopper MH, Tran SA, et al. Quest for quality: department of laboratory medicine and pathology, Mayo clinic. Clin Leadersh Manag Rev. 200418(6):361–363.
  • Mayo Clinic. Mayo Clinic Center for Innovation 2021 [cited 2021 Apr 15]. Available from: http://centerforinnovation.mayo.edu/what-we-do/
  • Israel Sheba Medical Center. ARC Innovation Center 2021. Available from: https://arc.sheba.co.il/
  • Smith B. CMS innovation center at 10 years – progress and lessons learned. N Engl J Med. 2021;384(8):759–764.
  • Voelker R. New center at FDA will advance digital health innovation. JAMA. 2020;324(17):1715.
  • Reddy A, Fihn SD, Liao JM. The VA MISSION Act - creating a center for innovation within the VA. N Engl J Med. 2019;380(17):1592–1594.
  • Rotenstein LS, Wickner P, Hauser L, et al. An academic medical center-based incubator to promote clinical innovation and financial value. Jt Comm J Qual Patient Saf. 2019;45(4):259–267.
  • Siefert AL, Cartiera MS, Khalid AN, et al. The Yale Center for Biomedical Innovation and Technology (CBIT): one model to accelerate impact from academic health care innovation. Acad Med. 2019;94(4):528–534.
  • Razak AA, White GRT. The triple helix model for innovation: a holistic exploration of barriers and enablers. IJBPSCM. 2015;7(3):278–291.
  • Giacomini KM, Lin L, Altman RB. Research projects supported by the University of California, san Francisco-Stanford center of excellence in regulatory science and innovation. Clin Pharmacol Ther. 2019;105(4):815–818.
  • Qoronfleh MW, Chouchane L, Mifsud B, et al. The FUTURE oF MEDICINE, healthcare innovation through precision medicine: policy case study of Qatar. Life Sci Soc Policy. 2020;16(1):12.
  • Mayo Clinic. The SPARC Lab 2008. Available from: https://www.fastcompany.com/magazine/104/sparc.html
  • Massachusetts General Hospital (MGH). CAMTech 2021 [cited 2021 Apr 15]. Available from: https://camtech.mgh.harvard.edu/
  • Helix N. Newcastle Helix: a global hub for COVID-19 innovations and solutions. [2020 Aug 5]. Available from: https://newcastlehelix.com/news/newcastle-helix-a-global-hub-for-covid-19-innovations-and-solutions

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.